CATALYST PHARMACEUTICALS, INC. 4
4 · CATALYST PHARMACEUTICALS, INC. · Filed Oct 23, 2015
Insider Transaction Report
Form 4
Winship M Douglas
V.P. of Regulatory Operations
Transactions
- Sale
Common stock, par value $0.001 per share
2015-10-23$3.34/sh−22,800$76,152→ 74,131 total
Footnotes (1)
- [F1]Shares were sold principally for the purpose of funding the exercise of stock options that will expire in November 2015. The exercise of the stock options using the proceeds of this sale will be reported in a separate Form 4.